MALIGNANT PLEURAL MESOTHELIOMA (MPM)
Clinical trials for MALIGNANT PLEURAL MESOTHELIOMA (MPM) explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PLEURAL MESOTHELIOMA (MPM) trials appear
Sign up with your email to follow new studies for MALIGNANT PLEURAL MESOTHELIOMA (MPM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill hopes to unleash immune system against tough cancers
Disease control Recruiting nowThis early-phase study tests an experimental pill called NX-1607 in adults with advanced cancers that have not responded to standard treatments. The drug aims to boost the body's immune system to fight tumors. The main goals are to check safety and see if the drug can shrink or c…
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA (MPM)
Phase: PHASE1 • Sponsor: Nurix Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Scientists map immune cells in rare cancer to boost treatment
Knowledge-focused Recruiting nowThis study looks at how the immune system interacts with malignant pleural mesothelioma, a rare and hard-to-treat cancer. Researchers will analyze tumor samples from 300 patients to understand why current immunotherapies help only some people. The goal is to find new ways to make…
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA (MPM)
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC